首页> 外文期刊>Clinical ophthalmology >Customized epithelial debridement for thin ectatic corneas undergoing corneal cross-linking: epithelial island cross-linking technique
【24h】

Customized epithelial debridement for thin ectatic corneas undergoing corneal cross-linking: epithelial island cross-linking technique

机译:进行角膜交联的薄层角膜的定制上皮清创术:上皮岛交联技术

获取原文
       

摘要

Abstract: Thin corneas with a minimum corneal thickness less than 400?μm after epithelial removal represent a contraindication to standard epithelium-off cross-linking (CXL) treatment due to a significant endothelial cell density decrease and potentiality of permanent haze development. Preoperative swelling of the cornea with hypoosmolar riboflavin solutions broadens the spectrum of CXL indications to thin corneas. However the iatrogenic swelling effect might not be durable throughout the CXL procedure increasing the risk of postoperative complications. The transepithelial CXL technique proposed for thin corneas demonstrated poor clinical results and mid- to long-term keratoconus instability. The epithelial island CXL technique with customized pachymetry-guided epithelial debridement was evaluated by means of in vivo laser scanning confocal microscopy, corneal topography, and clinical examination in a 1-year follow-up, in order to assess if it may be considered an alternative surgical option for keratoconic patients with thin corneas undergoing corneal collagen CXL. According to our clinical and in-vivo micro-morphological results the technique results safe, and efficacious in stabilizing progressive keratoconus and may be considered a valid option in the treatment of thin ectatic corneas alone or in combination with hypoosmolar or dextran-free riboflavin solutions.
机译:摘要:上皮去除后角膜厚度最小小于400?μm的薄角膜代表标准上皮脱落交联(CXL)治疗的禁忌症,这是由于内皮细胞密度显着降低和永久性雾霾发展的可能性。低渗性核黄素溶液可在术前使角膜肿胀,将CXL适应症的范围扩大至薄角膜。但是,在整个CXL手术过程中,医源性溶胀作用可能不会持久,从而增加了术后并发症的风险。建议用于薄角膜的经上皮CXL技术显示出较差的临床效果以及中长期圆锥角膜不稳定性。在1年的随访中,通过体内激光扫描共聚焦显微镜,角膜地形图和临床检查,评估了具有定制测厚仪引导的上皮清创术的上皮岛CXL技术,以评估它是否可以被认为是替代方法角膜胶原CXL的角膜较薄的圆锥角膜患者的手术选择。根据我们的临床和体内微观形态学结果,该技术可安全,有效地稳定进行性圆锥角膜,可单独或与低渗或无右旋糖酐的核黄素溶液联合使用,被认为是治疗薄直肠角膜的有效选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号